Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Vasculution AB
AB
Active
Org 5591728513
Honnörsgatan 6, 587 54
Linköping
Hospital activities
· NACE 8610
Est. 2018
1 employees
Watchlist
Share
Sweden
/
Companies
/
Hospital activities
/
Vasculution AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
843
642
559
672
713
Staff expenses
—
−26
−16
−258
−290
EBITDA
725
521
248
−146
14
Depreciation & amort.
−0
—
—
—
—
EBIT
725
521
248
−146
14
Net financials
—
−1
0
1
3
Profit before tax
545
383
355
35
17
Tax
−117
−85
−90
−16
−4
Net profit
428
298
265
19
12
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 557
1 576
1 520
1 321
1 267
Equity
810
754
919
838
750
Long-term debt
0
—
—
—
—
Short-term debt
461
398
284
346
379
Total debt
461
398
284
346
379
Financial ratios
5-year trend
EBITDA margin
1.9%
This company
15.8%
Market median
-88% vs market
2021
2025
Equity ratio
59.2%
This company
38.2%
Market median
+55% vs market
2021
2025
Return on equity
1.6%
This company
18.4%
Market median
-91% vs market
2021
2025
Net profit margin
1.7%
This company
8.1%
Market median
-79% vs market
2021
2025
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
2021
2025
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
More on Vasculution AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network